RJA
IBDS icon

Raymond James & Associates’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Raymond James & Associates’s Portfolio IBDS Stock Details IBDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$15.9M Buy
654,276
+40,870
+7% +$985K 0.01% 943
2024
Q2 		$14.6M Buy
613,406
+77,819
+15% +$1.84M 0.01% 947
2024
Q1 		$12.7M Buy
535,587
+83,657
+19% +$1.99M 0.01% 1026
2023
Q4 		$10.8M Buy
451,930
+82,520
+22% +$1.93M 0.01% 1060
2023
Q3 		$8.55M Buy
369,410
+39,377
+12% +$919K 0.01% 1136
2023
Q2 		$7.75M Sell
330,033
-10,296
-3% -$244K 0.01% 1218
2023
Q1 		$8.11M Sell
340,329
-12,552
-4% -$296K 0.01% 1157
2022
Q4 		$8.25M Buy
352,881
+8,212
+2% +$190K 0.01% 1104
2022
Q3 		$7.93M Buy
344,669
+127,343
+59% +$3.04M 0.01% 1085
2022
Q2 		$5.19M Buy
217,326
+83,944
+63% +$2.03M 0.01% 1387
2022
Q1 		$3.33M Buy
133,382
+40,738
+44% +$1.04M ﹤0.01% 1790
2021
Q4 		$2.46M Sell
92,644
-10,730
-10% -$286K ﹤0.01% 2022
2021
Q3 		$2.79M Buy
103,374
+6,027
+6% +$164K ﹤0.01% 1862
2021
Q2 		$2.63M Buy
97,347
+2,753
+3% +$74.2K ﹤0.01% 1905
2021
Q1 		$2.53M Buy
94,594
+7,398
+8% +$201K ﹤0.01% 1859
2020
Q4 		$2.4M Buy
87,196
+3,198
+4% +$87.3K ﹤0.01% 1787
2020
Q3 		$2.28M Buy
83,998
+11,211
+15% +$305K ﹤0.01% 1669
2020
Q2 		$1.96M Sell
72,787
-10,341
-12% -$269K ﹤0.01% 1739
2020
Q1 		$2.04M Sell
83,128
-126,743
-60% -$3.27M ﹤0.01% 1561
2019
Q4 		$5.46M Buy
209,871
+83,115
+66% +$2.15M 0.01% 1191
2019
Q3 		$3.29M Buy
126,756
+92,263
+267% +$2.37M ﹤0.01% 1492
2019
Q2 		$879K Buy
34,493
+197
+0.6% +$4.87K ﹤0.01% 2294
2019
Q1 		$841K Buy
34,296
+7,315
+27% +$175K ﹤0.01% 2306
2018
Q4 		$631K Sell
26,981
-2,875
-10% -$66.8K ﹤0.01% 2387
2018
Q3 		$703K Buy
29,856
+32
+0.1% +$757 ﹤0.01% 2473
2018
Q2 		$704K Buy
29,824
+986
+3% +$23.3K ﹤0.01% 2441
2018
Q1 		$694K Buy
+28,838
New +$700K ﹤0.01% 2363

Other funds holding IBDS

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.74B AUM 34.09% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Raymond James & Associates's IBDS Position: Q3 2024 in Review

Raymond James & Associates increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 6.7% in Q3 2024, buying an estimated $985K and bringing the position to 654,276 shares worth $15.9M. The position accounts for 0.01% of the portfolio, ranked #943.

Raymond James & Associates first reported a position in IBDS in Q1 2018 and has held it in 27 quarters since. 312 funds tracked by Wall St. Rank hold IBDS as of Q3 2024.

  • Raymond James & Associates held 654,276 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $15.9M as of Q3 2024.
  • Raymond James & Associates bought 40,870 iShares iBonds Dec 2027 Term Corporate ETF shares in Q3 2024, an estimated $985K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #943 holding.
  • Raymond James & Associates first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2018 and has held it in 27 quarters since.
  • 312 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.